MUC13通过依赖YAP1的途径驱动癌症的攻击性和转移
Kyle Doxtater1,2, Manish K Tripathi3,2, Radhika Sekhri4
1Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
素13 (MUC13) 通过增强菌的抗性和向YAP1.1,促进结直肠癌转移. 这种新型的MUC13-YAP1生存复合体驱动瘤细胞的生存和扩散,提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 转移是癌症进展的关键阶段,涉及癌细胞脱落期间的存活.
- 阿诺基的抗性对于癌细胞的生存和转移至关重要.
- 素13 (MUC13) 已与癌症有关,但其在转移中的作用尚未完全理解.
研究的目的:
- 研究MUC13在结直肠癌 (CRC) 转移中的作用.
- 阐明MUC13促进阿诺基斯耐药性和转移的分子机制.
- 为了确定抑制CRC转移的潜在治疗点.
主要方法:
- 利用整个动物模型系统研究结肠直肠癌细胞转移.
- 研究了MUC13和YAP1 (Yes相关蛋白1) 之间的相互作用.
- 在人类结直肠癌组织中分析了MUC13和YAP1的表达.
主要成果:
- MUC13调解阿诺基斯的抵抗力,并促进结直肠瘤细胞的存活,导致远程转移.
- MUC13的目标是YAP1,通过一个新的生存复合体驱动其核转移.
- 在动物模型中,高MUC13表达与广泛的巨转移和增加的核YAP1相关.
- 在人类CRC组织中观察到MUC13和YAP1表达之间的正相关性.
结论:
- 通过向YAP1.1,MUC13在结直肠癌转移中发挥着重要作用.
- MUC13-YAP1复合体增强了亲生存和转移相关的基因表达.
- 这项研究确定MUC13作为抗癌转移的新型治疗标.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
相关概念视频
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Cancer Cell Migration through Invadopodia
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene
Ras is a...
